How effective is lithium in the prevention of relapse in bipolar disorder? A prospective naturalistic follow-up study

Australian and New Zealand Journal of Psychiatry

Volumn 32, Issue 1, 1998, Pages 61-66

  Silverstone, Trevor ^a   McPherson, Heather ^a   Hunt, Neil ^b   Romans, Sarah ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b FULBOURN HOSPITAL   (United Kingdom)

Author keywords

Bipolar disorder; Carbamazepine; Lithium; Prophylaxis

Indexed keywords

CARBAMAZEPINE; LITHIUM; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; MOOD; NEW ZEALAND; PATIENT COMPLIANCE; RELAPSE; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; ANTIMANIC AGENTS; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LITHIUM CARBONATE; LONDON; MALE; MIDDLE AGED; NEW ZEALAND; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; RECURRENCE; TREATMENT OUTCOME;

EID: 0031956230     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1614.1998.0372a.x     Document Type: Article

References (32)

1. Silverstone T, Romans-Clarkson SE. Bipolar affective disorder: the causes and prevention of relapse. British Journal of Psychiatry 1989, 154 321-335
2. Goodwin FK, Jamison KR Manic-depressive illness. 1st ed. New York: Oxford University Press, 1990.
3. American Psychiatric Association. Practice guidelines for the treatment of patients with bipolar disorder. American Journal of Psychiatry 1994; 151:Supplement.
4. Baastrup PC, Poulsen JC, Schou M, Thomsen K, Amidsen A. Prophylactic lithium: double-blind discontinuation in manic-depressive and recurrent depressive disorders. Lancet 1970, ii:326-330.
5. Coppen A, Noguera R, Bailey J. Prophylactic lithium in affective disorders. Lancet 1971, ii:275-279.
6. Prien R, Caffey E, Klett J. Prophylactic efficacy of lithium carbonate in manic-depressive illness. Archives of General Psychiatry 1973; 28:337-341.
7. Harrow M, Goldberg JF, Grossman LS, Meltzer HY. Outcome in manic disorders: a naturalistic follow-up study. Archives of General Psychiatry 1990; 47:665-671.
8. Tohen M, Waternaux CM, Tsuang MT. Outcome in mania: a 4-year prospective follow-up of 75 patients utilising survival analysis Archives in General Psychiatry 1990; 47:1106-1111.
9. Winokur G, Coryell W, Keller M, Endicott J, Akiskal H A prospective follow-up of patients with bipolar and primary unipolar affective disorder. Archives in General Psychiatry 1993; 50:457-465.
10. McCreadie RG, Morrison DP. The impact of lithium in south west Scotland. British Journal of Psychiatry 1985; 146:70-80
11. Dickson WE, Kendell RE. Does maintenance lithium therapy prevent recurrences of mania under ordinary clinical conditions? Psychological Medicine 1986; 16:521-530.
12. Guscott R, Taylor L Lithium prophylaxis in recurrent affective illness: efficacy, effectiveness and efficiency. British Journal of Psychiatry 1994; 164:741-746.
13. Hunt N, Bruce-Jones W, Silverstone T. Life events and relapse in bipolar affective disorder. Journal of Affective Disorders 1992; 25:13-20.
14. McPherson HM, Romans SE. Life events and relapse in established bipolar affective disorder. British Journal of Psychiatry 1993; 163:381-385.
15. Silverstone T, Romans S, Hunt N, McPherson H. Is there a seasonal pattern of relapse in bipolar affective disorder? A dual northern and southern hemisphere cohort study. British Journal of Psychiatry 1995; 167:58-60.
16. Endicott J, Spitzer R A diagnostic interview: the schedule for affective disorders and schizophrenia. Archives of General Psychiatry 1978; 35:837-844.
17. Spitzer R, Endicott J, Robins E. Research diagnostic criteria: rationale and reliability. Archives of General Psychiatry 1978; 35:773-772.
18. Schou M. Lithium prophylaxis: about 'naturalistic' or 'clinical practice' studies Lithium 1993; 4:77-81
19. Dunner DL, Fieve RR Clinical factors in lithium carbonate prophylaxis failure. Archives of General Psychiatry 1974, 30:229-233.
20. Abou-Saleh MT. Who responds to prophylactic lithium therapy? British Journal of Psychiatry 1993; 163:20-26
21. Jerram TC, McDonald R. Plasma lithium control with particular reference to minimum effective levels. In: Johnson FN, Johnson S, eds. Lithium in medical practice. Lancaster: MTP Press. 1978:407-413.
22. Coppen A, Abou-Saleh MT. Lithium therapy: from clinical trials to practical management Acta Psychiatrica Scandinavica 1988, 78:744-762.
23. Sashidharan SP, McGuire RJ, Glenn AIM. Plasma lithium levels and therapeutic outcome in the prophylaxis of affective disorders: a retrospective study. British Journal of Psychiatry 1982; 140 619-622.
24. Gelenberg AJ, Kane JM, Keller MB et al. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. New England Journal of Medicine 1989; 321:1489-1493.
25. Aagaard J, Vestergaard P. Predictors of outcome in prophylactic lithium treatment: a 2-year prospective study. Journal of Affective Disorders 1990; 18:239-266.
26. Suppes T, Baldessarini RJ, Faedda GL. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Archives of General Psychiatry 1991; 48:1082-1088.
27. Prien RF, Potter WZ. NIMH workshop report on treatment of bipolar disorder. Psychopharmacology Bulletin 1990, 26:409-427.
28. Mander AJ, Loudon JB. Rapid recurrence of mania following abrupt discontinuation of lithium. Lancet 1988; ii:15-17.
29. Goodwin G. Recurrence of mania after lithium withdrawal. British Journal of Psychiatry 1994, 164:149-152.
30. Faedda GL, Tondo L, Baldassarini R, Suppes T, Tonen L Outcome after rapid vs. gradual discontinuation of lithium in bipolar disorders. Archives of General Psychiatry 1993; 50:448-455.
31. O'Connell R, Mayo J, Flatow L, Cuthbertson B, O'Brien B. Outcome of bipolar disorder on long term treatment with lithium. British Journal of Psychiatry 1991; 159:123-129.
32. Peselow ED, Fieve RR, Difiglia C, Sanfilipo MP. Lithium prophylaxis of bipolar disorder: the value of combination treatment. British Journal of Psychiatry 1994, 164:208-214.